Inhibition of 17B-estradiol metabolism by grapefruit juice in ovariectomized women
In an open, randomized, cross-over study the
concentrations of 17B-estradiol and estrone in serum were measured over 192 hours in 8
ovariectomized women after a single oral dose intake of 2 mg micronized 17B-estradiol. The
subjects were studied with and without grapefruit juice intake containing the three
natural flavonoids, naringenin, quercetin and kaempherol, which are found as glycosides in
citrus fruit. These flavonoids interact with the metabolism of drugs such as 17B-estradiol
and other steroids that are extensively metabolized through the P-45ONF (P450 IIIA4)
enzyme or closely related P-450 systems. After administration of grapefruit juice, peak
estrone (between 2-6 hours after tablet intake) concentrations increased significantly.
The AUC0-18 and AUC0-192 for estrone but not 17B-estradiol,
resulting from a single administration of micronized 17B-estradiol, were significantly
altered.
Combined measured estrogens (i.e. 17B-estradiol and estrone) also increased significantly.
The relationship between the AUCs for 17B-estradiol and estrone was not altered by juice
intake indicating that a metabolic step after estrone, i.e. further A and/or D ring
conversion was inhibited. This study demonstrates that grapefruit juice may alter the
metabolic degradation of estrogens, and increase the bioavailable amounts of 17B-estradiol
and its metabolite estrone, presumably by affecting the oxidative degradation of
estrogens. This food interaction may be one factor behind the interindividual variability
in 17B-estradiol, estrone and estriol serum concentrations after exogenous administration
of 17B-estradiol to patients.
Wemer Schubert, Goran Cullberg, Boo Edgar, Thomas Hedner
Department of Obstetrics and Gynaecology,
department of Clinical Pharmacology.
Sahigrenska University Hospital, S-41345 Gothenhurg, Sweden